×

Oral contraceptives

Ortho Women's Health

http://www.orthowomenshealth.com

The company's later research efforts focused on hormone combinations that could prevent pregnancy -- new insights that helped pave the way for the introduction of The Pill in 1960. This important research was recognized in 1966 when Ortho scientist, Carl Hartman, MD, was named the first recipient of the Margaret Sanger Award in Medicine. As the use of the Pill expanded widely in the 1970s, Ortho embarked on research to meet the contraceptive needs of women in all stages of life. Nursing mothers became the first beneficiaries with the introduction of ORTHO MICRONOR® (norethindrone), the first progestin-only birth control pill appropriate for nursing mothers. More than 20 years later, progestin-only contraception remains an excellent option for mothers who breast feed. In the 1980s, Ortho scientists used their growing knowledge to develop the first multiphasic birth control pills, ORTHO NOVUM® 10/11 (norethindrone/ethinyl estradiol) and ORTHO NOVUM® 7/7/7 (norethindrone/ethinyl estradiol). These pills mimicked the natural hormonal rhythms of a woman's menstrual cycle.

  • 12/8/2013
  • 7
  • 0

Schering AG

http://www.schering.de

Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: fertility control and hormone therapy, diagnostics and radiopharmaceuticals, dermatology as well as therapeutics for disabling diseases, e.g. multiple sclerosis, leukemia and solid tumors. As a global player with innovative products Schering AG aims for leading positions in specialized markets worldwide. With in-house R&D and supported by an excellent global network with external partners, Schering AG is securing a promising product pipeline. Using new ideas, Schering AG aims to make a recognized contribution to medical progress and strives to improve the quality of life.

  • 12/8/2013
  • 6
  • 0

Note

Not found any data